San Pedro Cactus (Echinopsis pachanoi)
What Is San Pedro Cactus?
San Pedro Cactus is catalogued in the Materia Medica under the binomial Echinopsis pachanoi, a plant of the Cactaceae family, native to the Andes of Peru and Bolivia. The material in circulation is stem / cortex (ethnobotanical). The common name San Pedro Cactus and the botanical name Echinopsis pachanoi refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. In the hand it reads as green, mucilaginous, sharply bitter — a practical marker of freshness and correct identification.
The written history of San Pedro Cactus begins with household and practitioner use — recipes, harvesting notes and cautions passed between regions — and only much later with laboratory description of what the stem / cortex (ethnobotanical) contains. Beyond its practical use it carries cultural associations — huachuma — the 'plant that removes the veil' in northern Peruvian shamanism.
Today most searches for San Pedro Cactus come from people reading about focus and weight management, or checking how it sits alongside a medication they already take. The use most often documented in the literature is long-standing use in Peruvian curanderismo for diagnostic and healing ceremony, followed by mescaline studied as a 5-HT2A research ligand.
How Does San Pedro Cactus Work?
San Pedro Cactus works as a mixture rather than a single isolated compound, and its profile is usually described by the class of constituents present in stem / cortex (ethnobotanical) rather than by one marker molecule.
Before its chemistry was known, San Pedro Cactus was judged by what it did in the cup: how strongly it brewed, how it tasted, and how little or much was needed. Those notes are why particular preparations survived and others did not.
Published research is limited, leaning on small trials, laboratory work and animal models, and this profile cites 1 source. Reported findings centre on mescaline concentrates in the green chlorophyll-bearing cortex at roughly 0.05–0.3% fresh weight, with wide clonal variation. Where research exists, it examines long-standing use in Peruvian curanderismo for diagnostic and healing ceremony, mescaline studied as a 5-HT2A research ligand and ornamental and grafting-stock horticultural value. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
San Pedro Cactus is studied as a whole preparation because isolating one fraction tends to behave differently from the material it was taken out of — a recurring finding across the plant-chemistry literature.
Because these constituents are processed by the same pathways that handle many medicines, San Pedro Cactus is documented as interacting with ssris / snris, mao inhibitors and lithium. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name San Pedro Cactus can differ substantially; this is why reference entries specify stem / cortex (ethnobotanical) and, where they exist, standardisation markers.